Den europeiske union -
rumensk -
EMA (European Medicines Agency)
byooviz
samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmologice - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
Moldova -
rumensk -
AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)
erolin 10 mg comprimate
egis pharmaceuticals plc - loratadinum - comprimate - 10 mg
Moldova -
rumensk -
AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)
erolin 1 mg/ml sirop
egis pharmaceuticals plc - loratadinum - sirop - 1 mg/ml
Moldova -
rumensk -
AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)
tiomax 600 mg comprimate filmate
sc balkan pharmaceuticals srl - acid thiocticum - comprimate filmate - 600 mg
Den europeiske union -
rumensk -
EMA (European Medicines Agency)
epysqli
samsung bioepis nl b.v. - eculizumab - hemoglobinurie, paroxismal - imunosupresoare - epysqli is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). evidence of clinical benefit is demonstrated in patients with haemolysis with clinical symptom(s) indicative of high disease activity, regardless of transfusion history.